Active, not recruitingPhase 2NCT06087757
Clemastine Treatment in Individuals With Williams Syndrome
Studying Williams syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Sheba Medical Center
- Intervention
- Open Label Clemastine with a blinded randomize withdrawal(drug)
- Enrollment
- 30 enrolled
- Eligibility
- 6-30 years · All sexes
- Timeline
- 2024 – 2026
Study locations (2)
- Child and Adolescent Psychiatry Unit, Sheba Medical Center, Ramat Gan, Israel
- Tel Aviv University, Tel Aviv, Israel
Collaborators
Tel Aviv University
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06087757 on ClinicalTrials.govOther trials for Williams syndrome
Additional recruiting or active studies for the same condition.